Oral sensorimotor defects in patients with Parkinson's disease
Diamond, S.G.; Schneider, J.S.; Markham, C.H.
Advances in Neurology 45: 335-338
1987
ISSN/ISBN: 0091-3952 PMID: 3825706 Document Number: 294632
Document emailed within 1 workday
Related Documents
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283Sweet, R.D.; Wasterlain, C.; McDowell, F.H. 1974: Piribedil--an oral dopamine agonist for treatment of Parkinson's disease Transactions of the American Neurological Association 99: 258-260
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
Sale, P.; De Pandis, M.F.; Vimercati, S.L.; Sova, I.; Foti, C.; Tenore, N.; Fini, M.; Stocchi, F.; Albertini, G.; Franceschini, M.; Galli, M. 2013: The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects European Journal of Physical and Rehabilitation Medicine 49(2): 161-167
Mitchell, A.A.; Rosenberg, L.; Shapiro, S.; Slone, D. 1981: Birth defects related to bendectin use in pregnancy. I. Oral clefts and cardiac defects JAMA 245(22): 2311-2314
Poungvarin, N.; Viriyavejakul, A. 1990: L-deprenyl therapy in Thai patients with Parkinson's disease: before and after, clinical trial of 50 patients Journal of the Medical Association of Thailand 73(7): 381-386
Alicock, L.M. 2007: Managing patients with Parkinson's disease Practitioner 251(1694): 51; 53 55-516 Passim
Georgiev, D.; Danieli, A.; Ocepek, L.; Novak, D.; Zupancic-Kriznar, N.; Trost, M.; Pirtosek, Z. 2010: Othello syndrome in patients with Parkinson's disease Psychiatria Danubina 22(1): 94-98
Kidron, D.; Melamed, E. 1987: Forms of dystonia in patients with Parkinson's disease Neurology 37(6): 1009-1011
Kashihara, K. 2017: Neuropsychiatric symptoms in patients with Parkinson's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 75(1): 105-110
Idjadi, J.A.; Aharonoff, G.B.; Su, H.; Richmond, J.; Egol, K.A.; Zuckerman, J.D.; Koval, K.J. 2005: Hip fracture outcomes in patients with Parkinson's disease American Journal of Orthopedics 34(7): 341-346
Thomsen, V.Frølund. 2007: Hardly suffering families of patients with Parkinson disease Ugeskrift for Laeger 169(39): 3309
De Quintana-Schmidt, C.; Pascual-Sedano, B.; Alvarez-Holzapfel, M.J.ús.; Gironell, A.; Leidinger, A.; Benito, N.; Rodríguez-Rodríguez, R.; Molet-Teixidó, J. 2014: Complications related with implanted devices in patients with Parkinson's disease treated with deep brain stimulation. a study of a series of 124 patients over a period of 16 years Revista de Neurologia 59(2): 49-56
Neshige, R. 2005: Optimum dosage of pergolide in patients with Parkinson's disease Rinsho Shinkeigaku 45(4): 328-330
Sica, R.E.; Aguilera, N.; Herskovits, E. 1972: Impaired potentiation of H-reflexes in patients with Parkinson's disease Medicina 32(6): 588-595
Koliada, A.K.; Vaĭserman, A.M.; Krasnenkov, D.S.; Karaban', I.N. 2014: The study of telomere length in patients with Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(8): 58-61
Cassani, E.; Privitera, G.; Pezzoli, G.; Pusani, C.; Madio, C.; Iorio, L.; Barichella, M. 2011: Use of probiotics for the treatment of constipation in Parkinson's disease patients Minerva Gastroenterologica e Dietologica 57(2): 117-121
Van Laar, T.; Boon, A.J.W.; Bloem, B.R. 2010: Rasagiline is not for all Parkinson disease patients: the ADAGIO study Nederlands Tijdschrift Voor Geneeskunde 154: A2496
Sobolewski, P. 2003: Treatment of Parkinson disease in patients with surgical problems Neurologia i Neurochirurgia Polska 37(Suppl 5): 183-188